Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection
Year: 2015
Type: article
Study design: Observational Study
Abstract: HLA class I polymorphism has a major influence on adult HIV disease progression. An important mechanism mediating this effect is the impact on viral replicative capacity (VRC) of the escape mutations selected in response to HLA-restricted CD8+ T-cell responses. Factors that contribute to slow progression in pediatric HIV infection are less well understood. We here investigate the relationship between VRC and disease progression in pediatric infection, and the effect of HLA on VRC and on disease outcome in adult and pediatric infection. Studying a South African cohort of >350 ART-naïve, HIV-infected children and their mothers, we first observed that pediatric disease progression is significantly correlated with VRC. As expected, VRCs in mother-child pairs were strongly correlated (p = 0.004). The impact of the protective HLA alleles, HLA-B*57, HLA-B*58:01 and HLA-B*81:01, resulted in significantly lower VRCs in adults (p<0.0001), but not in children. Similarly, in adults, but not in children, VRCs were significantly higher in subjects expressing the disease-susceptible alleles HLA-B*18:01/45:01/58:02 (p = 0.007). Irrespective of the subject, VRCs were strongly correlated with the number of Gag CD8+ T-cell escape mutants driven by HLA-B*57/58:01/81:01 present in each virus (p = 0.0002). In contrast to the impact of VRC common to progression in adults and children, the HLA effects on disease outcome, that are substantial in adults, are small and statistically insignificant in infected children. These data further highlight the important role that VRC plays both in adult and pediatric progression, and demonstrate that HLA-independent factors, yet to be fully defined, are predominantly responsible for pediatric non-progression.
Source: PLoS Pathogens
Authors: Emily Adland, Paolo Paioni, Christina Thobakgale, Leana Laker, Luisa Mori, Maximilian Muenchhoff, Anna Csala, Margaret Clapson, Jacquie Flynn, Vas Novelli, Jacob Hurst, Vanessa Naidoo, Roger Shapiro, Kuan-Hsiang Gary Huang, John Frater, Andrew Prendergast, Julia G. Prado, Thumbi Ndung’u, Bruce D. Walker, Mary Carrington, Pieter Jooste, Philip J. R. Goulder
Institutions: University of Oxford, Medawar Building for Pathogen Research, University of KwaZulu-Natal, Kimberley Hospital, Great Ormond Street Hospital, Botswana Harvard AIDS Institute Partnership, Queen Mary University of London, Zvitambo Institute for Maternal and Child Health Research, Blizard Institute, IrsiCaixa, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Harvard University, Ragon Institute of MGH, MIT and Harvard, Max Planck Institute for Infection Biology, Massachusetts General Hospital, Massachusetts Institute of Technology, National Cancer Institute, Center for Cancer Research
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,043
Funders: Howard Hughes Medical Institute, Wellcome Trust, National Institute for Health and Care Research, Department of Science and Technology, Ministry of Science and Technology, India, Victor Daitz Foundation, Medical Research Council, Instituto de Salud Carlos III, National Institute of Allergy and Infectious Diseases
OpenAlex ID: W2156096572
